Index




Note: Page numbers of article titles are in boldface type.


A


Allograft(s)


in static rehabilitation of paralyzed midface, 31


Antiviral agents


in Bell’s palsy management, 7


Autologous tissue grafts


in static rehabilitation of paralyzed midface, 30




B


Bell’s palsy, 1–10


anatomy of facial nerve in, 1–2


causes of, 2


diagnosis of, 2–6


facial assessment in, 3


differential diagnosis of, 4


incidence of, 2


introduction, 1


management of, 6–8


antiviral agents in, 7


corticosteroids in, 6–7


long-term, 8


outcomes of, 7


physical therapy in, 7


surgical decompression in, 6


synkinesis following, 8


Botulinum toxin


in facial paralysis management, 11–20


contralateral normal side


asymmetry-related, 17


future directions in, 18


introduction, 11–12


neuromodulator injection with, 15–16


NMR with, 13–15


options in, 13–17


patient evaluation prior to, 12–13


risks associated with, 17




B


Bell’s palsy, 1–10


anatomy of facial nerve in, 1–2


causes of, 2


diagnosis of, 2–6


facial assessment in, 3


differential diagnosis of, 4


incidence of, 2


introduction, 1


management of, 6–8


antiviral agents in, 7


corticosteroids in, 6–7


long-term, 8


outcomes of, 7


physical therapy in, 7


surgical decompression in, 6


synkinesis following, 8


Botulinum toxin


in facial paralysis management, 11–20


contralateral normal side


asymmetry-related, 17


future directions in, 18


introduction, 11–12


neuromodulator injection with, 15–16


NMR with, 13–15


options in, 13–17


patient evaluation prior to, 12–13


risks associated with, 17




C


Corticosteroid(s)


in Bell’s palsy management, 6–7




E


Eye(s)


in facial paralysis


assessment of, 22–23


management of, 21–28


anatomy related to, 23–25


introduction, 21–22


lower eyelid tightening, 26–27


operative technique, 25


surgical indications, 23


upper eyelid loading, 25–26


Eyelid(s)


lower


tightening of


in facial paralysis management, 26–27


upper


loading


in facial paralysis management, 25–26




F


Facial nerve


anatomy of, 1–2


Facial paralysis, 1–10 . See also Bell’s palsy


consequences of, 21–22


correction of, 29–35


alternative therapies in, 17–18


botulinum toxin in, 11–20 ( See also Botulinum toxin, in facial paralysis management)


eye management in, 21–28 ( See also Eye(s), in facial paralysis, management of)


future directions in, 18


gracilis free flap in, 47–60 ( See also Gracilis free flap)


introduction, 29–30


midface


static rehabilitation, 30–31


nerve repair in, 72–81 ( See also Facial reanimation, components of)


sternohyoid flap in, 61–69 ( See also Sternohyoid flap, for facial reanimation)


surgical techniques in, 29–35


introduction, 29–30


percutaneous suture–based slings, 32–34


rhytidectomy, 31


static suspension sling, 31–32


differential diagnosis of, 4


introduction, 1


nerve anatomy related to, 72


nerve injury process in, 71–72


smile restoration after


temporal MTU transfer in, 37–45 ( See also Temporalis muscle tendon unit (MTU) transfer, for smile restoration after facial paralysis)


Facial reanimation, 71–84


components of


babysitter and cross-facial nerve grafting, 77–78


hypoglossal-facial nerve, 75–76


masseteric-facial nerve, 76–77


motor vs. sensory donor nerve graft, 74


nerve graft polarity effects, 74


nerve substitution, 75


nonbiologic conduits, 74–75


primary suture repair, 72–74


variations in nerve substitution procedures, 78–81


correction of


emerging technologies in, 81–82


described, 71


introduction, 71


Facial slings


static, 29–35 ( See also Static facial slings)


Flap(s)


in facial paralysis correction ( See specific types )

Only gold members can continue reading. Log In or Register to continue

Feb 8, 2017 | Posted by in General Surgery | Comments Off on Index
Premium Wordpress Themes by UFO Themes